Ailurus Biotechnology
PrivateLast Round
Angel
Oct 27, 2021
Total Funding Raised
$3.1M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Ailurus Biotechnology operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was an Angel round in October 2021.
Ailurus Biotechnology is a synthetic biology company that develops biocomputing platforms and automated workflows to streamline protein engineering and scientific discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment, Workflow Automation
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ailurus Biotechnology Comparables
Compare Ailurus Biotechnology with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Adaptyv Bio | 83% | |
| BigHat Biosciences | 77% | |
| Liberum Biotech | 75% |
For institutional investors. Book with your work email.
Ailurus Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Oct 27, 2021 | ||||
| Accelerator | Oct 12, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ailurus Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GeniLink Capital | Angel |
| 5Y Capital | Angel |
| MiraclePlus | Accelerator, Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 12, 2026
Monthly visitors grew 452% MoM, reaching 36.7K.
- Jul 24, 2026
Monthly visitors grew 36% MoM, reaching 5.2K.
For institutional investors. Book with your work email.
Ailurus Biotechnology Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ailurus Biotechnology's valuation, stock price, and market status.
Is Ailurus Biotechnology a public or private company?
Ailurus Biotechnology is a private company.
What is the current stock price of Ailurus Biotechnology?
Ailurus Biotechnology is a private company, so its shares have no public market price. Caplight tracks Ailurus Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ailurus Biotechnology worth (valuation)?
Valuation information for Ailurus Biotechnology is not publicly available.
Can I buy Ailurus Biotechnology stock?
Ailurus Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ailurus Biotechnology's last funding round?
Ailurus Biotechnology's most recent funding round was Angel on October 27, 2021.
Who are the main investors in Ailurus Biotechnology?
Key investors in Ailurus Biotechnology include GeniLink Capital.
Will Ailurus Biotechnology IPO soon?
No public IPO plans have been announced for Ailurus Biotechnology.
How can I track Ailurus Biotechnology secondary market activity?
Caplight tracks bids, offers, and trades in Ailurus Biotechnology's shares on secondary markets.